Literature DB >> 8304826

Inhibition of nitric oxide synthesis is detrimental during endotoxemia.

E A Minnard1, J Shou, H Naama, A Cech, H Gallagher, J M Daly.   

Abstract

BACKGROUND: Increased production of nitric oxide has been implicated as a mediator during septic shock and sepsis syndrome. Inhibition of nitric oxide production could be beneficial during endotoxemia to improve the individual's hemodynamic status and possibly outcome.
OBJECTIVE: To evaluate the effects of nitric oxide inhibition on macrophage function and survival in a murine sepsis model.
DESIGN: Sixty-eight female Swiss-Webster (ND4) mice were injected with a sublethal dose of Escherichia coli lipopolysaccharide (25 mg/kg). INTERVENTION: The treated group (n = 34) received 10 mg/kg of NG-nitro-L-arginine methyl ester at the time of lipopolysaccharide injection. MAIN OUTCOME MEASURES: Blood samples and peritoneal macrophages were obtained at baseline and at 2, 4, and 8 hours after injection. Nitrite levels were measured in 36 mice from plasma and supernatant samples of cultured peritoneal macrophages stimulated with interferon gamma (100 micrograms/mL) for 48 hours. Thirty-two animals were observed for survival.
RESULTS: Administration of N-nitro-L-arginine methyl ester after lipopolysaccharide injection caused significant reductions in macrophage mean nitrite production from 13 and 15 mumol/L to 7 and 11 mumol/L (P < .05) and reduced mean plasma nitrite concentrations from 100 and 118 mumol/L to 46 and 108 mumol/L (P < .05) at 2 and 4 hours, respectively. The rate of survival was significantly decreased to 0% in the group receiving N-nitro-L-arginine methyl ester after septic challenge compared with 87.5% in controls (P < .005).
CONCLUSIONS: Inhibition of nitric oxide production is detrimental in this murine model of endotoxemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8304826     DOI: 10.1001/archsurg.1994.01420260038004

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  13 in total

1.  Efficacy of treatment with the iron (III) complex of diethylenetriamine pentaacetic acid in mice and primates inoculated with live lethal dose 100 Escherichia coli.

Authors:  L Molina; S Studenberg; G Wolberg; W Kazmierski; J Wilson; A Tadepalli; A C Chang; S Kosanke; L Hinshaw
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Effects ofL-arginine andN-nitro-L-arginine treatment on hemodynamics, DO2, VO 2, and extravascular lung water in a dog endotoxin shock model.

Authors:  X Wu; S Zhang; G Shan
Journal:  J Anesth       Date:  1997-06       Impact factor: 2.078

3.  Immunomodulation of pneumococcal pulmonary infection with N(G)-monomethyl-L-arginine.

Authors:  Y Bergeron; N Ouellet; M Simard; M Olivier; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

4.  Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.

Authors:  V E Laubach; E G Shesely; O Smithies; P A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

5.  Effects of nitro-L-arginine on blood pressure and cardiac index in anesthetized rats: a pharmacokinetic-pharmacodynamic analysis.

Authors:  M A Tabrizi-Fard; H L Fung
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

6.  An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality.

Authors:  M Bianchi; P Ulrich; O Bloom; M Meistrell; G A Zimmerman; H Schmidtmayerova; M Bukrinsky; T Donnelley; R Bucala; B Sherry
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

Review 7.  Role of nitric oxide in anaphylactic shock.

Authors:  H Mitsuhata; R Shimizu; M M Yokoyama
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

8.  Effects of three inhibitors of nitric oxide synthase on host resistance to bacterial infection.

Authors:  K Fukatsu; H Saito; R Fukushima; M T Lin; T Inoue; T Inaba; S Furukawa; I Han; T Muto
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

9.  Induction of adrenomedullin mRNA and protein by lipopolysaccharide and paclitaxel (Taxol) in murine macrophages.

Authors:  M Zaks-Zilberman; C A Salkowski; T Elsasser; F Cuttitta; S N Vogel
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 10.  Nitric oxide. Novel biology with clinical relevance.

Authors:  T R Billiar
Journal:  Ann Surg       Date:  1995-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.